Related Experiment Video
Updated: Aug 5, 2026

06:00
Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection
Published on: December 30, 2025
Minimally Invasive Versus Open Liver Resection for HCC in the Posterosuperior Segments: A Propensity Score-matched
Hisamune Sakai1, Yuichi Goto2, Shogo Fukutomi2
1Kurume University School of Medicine, Department of Surgery, Kurume, Japan hisamune@med.kurume-u.ac.jp.
Anticancer Research
|July 29, 2026
Summary
Minimally invasive liver resection (MILR) for hepatocellular carcinoma (HCC) in difficult-to-reach liver segments offers better perioperative results. MILR is safe and feasible, showing comparable long-term oncological outcomes to open liver resection (OLR).
Area of Science:
- Hepatobiliary surgery
- Surgical oncology
- Minimally invasive surgery
Background:
- Hepatocellular carcinoma (HCC) in the posterosuperior segments (7 and 8) presents surgical challenges.
- Minimally invasive liver resection (MILR) is increasingly adopted, but its efficacy for these specific HCC locations needs evaluation.
- Open liver resection (OLR) is the traditional approach for these resections.
Purpose of the Study:
- To compare perioperative and oncological outcomes of MILR versus OLR for HCC in posterosuperior liver segments.
- To evaluate the safety and feasibility of MILR in this challenging anatomical location.
- To assess long-term survival and recurrence rates between the two surgical approaches.
Main Methods:
- Retrospective analysis of 157 patients with HCC in segments 7/8 (80 MILR, 77 OLR).
- Propensity score matching created comparable groups of 39 patients each (MILR vs. OLR).
- Outcomes analyzed included intraoperative blood loss, transfusion rates, operative time, morbidity, hospital stay, overall survival, and recurrence-free survival.
Main Results:
- MILR group had significantly less blood loss (55 vs. 330 ml), lower transfusion rates (0% vs. 18%), shorter operative times (288 vs. 338 min), and reduced postoperative morbidity (0% vs. 33.3%).
- MILR patients experienced shorter hospital stays (8 vs. 15 days).
- No significant differences were observed in 1-, 3-, and 5-year overall survival and recurrence-free survival rates between MILR and OLR groups.
Conclusions:
- MILR for HCC in posterosuperior liver segments is a safe and feasible alternative to OLR.
- MILR offers significant advantages in perioperative outcomes without compromising long-term oncological results.
- These findings support the adoption of MILR for carefully selected patients undergoing resection for HCC in these segments.
